期刊文献+

肝星状细胞的抗原提呈特性

Antigen presenfing characteristic of hepatic stellate cells
原文传递
导出
摘要 肝星状细胞(hepatic stellate cells,HSC),曾被称为n0细胞、窦周细胞、脂细胞和贮脂细胞。由德国学者Kupffer在1876年首先用氯化金染色确认,称之为stemzellen,当时曾被误认为是一种肝内吞噬细胞。1951年,no用电镜观察将窦周HSC与窦内Kupffer细胞(肝吞噬细胞)予以清楚鉴别。1996年国际上将该细胞统—命名为HSC。
作者 吴眉 徐列明
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2012年第11期874-876,共3页 Chinese Journal of Hepatology
关键词 肝硬化 肝纤维化 肝星状细胞 抗原提呈功能 Liver cirrhosis Hepatic fibrosis Hepatic stellatecells Antigen-presentation
  • 相关文献

参考文献28

  • 1Hepatic stellate cell nomenclature. Hepatology, 1996, 23: 193.
  • 2Baba S, Fujii H, Hirose T, et al. Commitment of bone marrow ceils to hepatic stellate cells in mouse. J Hepatol, 2004, 40: 255-260.
  • 3Friedman SL. Hepatic stellate ceils: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev, 2008, 88: 125-172.
  • 4Winau F, Hegasy G, Weiskirchen R, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity, 2007, 26: 117-129.
  • 5Maubach G, Lira MC, Kumar S, et al. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment. Biochim Biophys Acta, 2007, 1773:219-231.
  • 6陆金春,黄宇烽,张锡然,等.英汉细胞与分子生物学词典.上海:第二军医大学出版社,2004:49.
  • 7Gao B, Jeong WI, Tian Z. Liver: an organ with predominant innate immunity. Hepatology, 2008, 47: 729-736.
  • 8Bomble M, Tacke F, Rink L, et al. Analysis of antigen-presenting functionality of cultured rat hepatic stellate cells and transdifferentiated myofibroblasts. Biochem Biophys Res Commun, 2010, 396: 342-347.
  • 9Vifias O, Bataller R, Sancho-Bru P, et al. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology, 2003, 38: 919-929.
  • 10Schwabe RF, Schnabl B, Kweon YO, et al. CD40 activates NF- kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic steUate cells. J Immunol, 2001, 166: 6812-6819.

二级参考文献27

  • 1Bataller R, Brenner DA. Liver fibrosis [ J]. J Clin Invest ,2005,115 (2) :209-218.
  • 2Friedman SL. Mechanisms of hepatic fibrogenesis [ J ]. Gastroenter- ology ,2008,134 ( 6 ) : 1655 -1669.
  • 3Beutler B. Inferences, questions and possibilities in Toll-like recep- tor signaling[ J]. Nature ,2004,430 ( 6996 ) :257-263.
  • 4Katsargyris A, Klonaris C, Alexandrou A, et al. Toll-like recep- tors in liver ischemia reperfusion injury: a novel target for thera- peutic modulation? [ J]. Expert Opin Ther Targets, 2009,13 (4) :427-442.
  • 5Beutler B. The toll-like receptors : analysis by forward genetic meth- ods [ J ]. Immunogenetics, 2005,57 ( 6 ) : 385 -392.
  • 6Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity [ J ]. Cell, 2006,124 ( 4 ) :783-801.
  • 7Liew FY, Xu D, Brint EK, et al. Negative regulation of toll-like pe- ceptor-mediated immune responses [ J ]. Nat Rev Immunol, 2005,5 (6) :446-458.
  • 8Paik YH, Schwabe RF, Bataller R, et al. Toll-like receptor 4 me- diates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells [ J ]. Hepatology, 2003,37 ( 5 ) : 1043- 1055.
  • 9Seki E, De Minicis S, Osterricher CH, et al. TLR4 enhances TGF- beta signaling and hepatic fibrosis [ J ]. Nat Med, 2007,13 ( 11 ) : 1324-1332.
  • 10Takeda K, Akira S. Toll-like receptors in innate immunity [ J ]. Int Immuno1,2005,17 ( 1 ) : 1-14.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部